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Abstract It has been suggested that the age-related
decrease in the number of neurons in the hippocampus
that leads to alterations in brain function, may be
associated with an increase in apoptosis due to the
reduced secretion of growth hormone (GH) and/or
melatonin in old animals. In order to investigate this
possibility, male Wistar rats of 22 months of age were
divided into three groups. One group remained
untreated and acted as the control group. The second
was treated with growth hormone (hGH) for 10 weeks
(2 mg/kg/d sc) and the third was subjected to melato-
nin treatment (1 mg/kg/d) in the drinking water for the
same time. A group of 2-months-old male rats was used
as young controls. All rats were killed by decapitation
at more than 24 month of age and dentate gyri of the
hippocampi were collected. Aging in the dentate gyrus
was associated with an increase in apoptosis promoting
markers (Bax, Bad and AIF) and with the reduction of
some anti-apoptotic ones (XIAP, NIAP, Mcl-1).
Expressions of sirtuin 1 and 2 (SIRT1 and 2) as well
as levels of HSP 70 were decreased in the dentate gyrus
of old rats. GH treatment was able to reduce the pro/
anti-apoptotic ratio to levels observed in young
animals and also to increase SIRT2. Melatonin reduced
also expression of pro-apoptotic genes and proteins
(Bax, Bad and AIF), and increased levels of myeloid
cell leukemia-1 proteins and SIRT1. Both treatments
were able to reduce apoptosis and to enhance survival
markers in this part of the hippocampus.
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Abbreviation
NIAP Neuronal inhibitor apoptosis protein
XIAP X-linked inhibitor of apoptosis protein
AIF Apoptosis-inducing factor
Mcl-1 Myeloid cell leukemia-1
SIRT1 and 2 Sirtuin 1 and 2
HSPs Heat shock proteins
GH Growth hormone
Bad Bcl-2-associated death promoter
Bax Bcl-2-associated X protein
Bak Bcl-2 homologous antagonist/killer
Endo G Endonuclease G
PI3K Phosphatidylinositol 3-kinases
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AKT Protein kinase B (PKB), is a serine/
threonine-specific protein kinase
cAMP Cyclic adenosine monophosphate
IGF-I Insulin like growth factor
Bcl-2 B-cell lymphoma 2
CNS Central nervous system
Introduction
The hippocampus is a target of age-related physiolog-
ical and structural changes. Alterations in the hippo-
campus during aging are paralleled by behavioral and
functional deficits in hippocampus-dependent learning
and memory tasks (Rosenzweig and Barnes 2003).
Recent microarray studies of hippocampal gene expres-
sion, identified several aging-dependent upregulated
processes, including lipid catabolism, proteolysis, cho-
lesterol transport, and myelinogenesis in normally
aging rats (Rowe et al. 2007; Kadish et al. 2009).
In humans, apoptosis occurs in the developing
nervous system to eliminate neurons with erroneous or
inadequate projections (Chan et al. 2002), whereas
enhanced apoptosis in the adult brain is also charac-
teristic of several pathologies of the central nervous
system (CNS) (Mattson 2006; Kim and Sun 2011). It
has been suggested that the decrease in the number of
neurons by apoptosis may be associated with trophic
factor(s) deprivation (Ambacher et al. 2012) or with
the absence or reduction of anti-apoptotic proteins
such as B-cell lymphoma 2 (Bcl-2) (Allsopp et al.
1993). Many apoptosis-related factors have been
demonstrated to be up-regulated in the immature
brain, such as caspase-3, Apaf-1 and Bcl-2-associated
X protein (Bax) (Ota et al. 2002; Troy et al. 2011).
Inhibitor of apoptosis (IAP) family of proteins like
neuronal inhibitor apoptosis protein (NIAP), X-linked
inhibitor of apoptosis protein (XIAP), and cIAP-2 play
also a role in the regulation of neuronal death and in
several models of disease. NIAP directly inhibits
caspase-3, -7, and -9 and XIAP directly inhibits also
caspase-3 and caspase-7 (Prunell and Troy 2004).
Sirtuin1 (SIRT1) is a mammalian nicotinamide
adenine dinucleotide (NAD)-dependent histone
deacetylase (HDAC) that down-regulates the acetyla-
tion levels of many regulatory proteins involved in
energy homeostasis, DNA repair, cell survival, and
lifespan extension (Kwon and Ott 2008). SIRT1 has
been shown to be associated with reduced apoptosis,
whereas inactivation of SIRT1 could on the contrary
promote translocation of Bax from the cytosol to
mitochondria (Cohen et al. 2004). SIRT1 also protects
against amyloid-b toxicity in cell culture and neuro-
degeneration in the p25/CDK5 mouse model, which
recapitulates aspects of Alzheimer’s disease pathology
and tauopathy (Kim et al. 2007).
Activity of the growth hormone (GH)/insulin like
growth factor (IGF-I) axis undergoes an age-related
decline, including reduced spontaneous GH secretion
and circulating IGF-I levels, which may reach values
that are similar to those found in GH-deficient patients
(Ghigo et al. 2000). In both elderly and GH-deficient
adults, this decreased GH/IGF-I activity has been
associated with changes in body composition and
metabolism, altered sleep patterns and reduced cog-
nitive function. GH replacement therapy has been
found to improve some age-dependent cognitive
functions, such as memory, motivation, or mental
processing speed (Nass et al. 2009; Quik et al. 2010).
In a dwarf rat model with reduced levels of serum GH
and IGF1 beginning before adolescence, early inter-
vention with GH for 10 weeks starting around puberty
was reported to ameliorate age-related pathology in
later life and increase lifespan (Sonntag et al. 2005). A
significant decrease has been observed in the density
of GH binding with increasing age (over 60 years old)
in the choroid plexus, hypothalamus, hippocampus,
pituitary, and putamen (Lai et al. 1993). Progressive
loss of activated precursors and neurons has been
shown to correlate with an age-dependent decline in
GH secretion in both rodents and humans (Nieves-
Martinez et al. 2010). Knock-down of GH by gene
silencing in cells of this cultured embryonic neural
retina cell line, using NR-cGH-1 siRNA, correlates
with the increased appearance in the cultures of cells
with apoptotic nuclear morphology (Sanders et al.
2010).
Melatonin binding sites do also exist in the
hippocampus of several mammals. MT1 and MT2
receptors have been localized in the dentate gyrus,
CA3 and CA1 regions and subiculum of the hippo-
campus (Musshoff et al. 2002). Melatonin production
by the pineal is severely restricted in advanced age in
humans as well as in experimental animals. Other
studies have demonstrated an age-related decrease of
2-[125]-iodomelatonin binding and MT1 mRNA in
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the CNS of rat and mice (Pandi-Perumal et al. 2008).
For instance, Laudon et al. (1988) reported an age-
related lowering in the density of melatonin binding
sites in discrete rat hypothalamic and hippocampal
areas. Many experimental data have demonstrated
that, melatonin is an anti-apoptotic mediator. So,
melatonin supplementation was able to inhibit apop-
tosis in amyloid b-peptide (Ab) injury in hippocampal
neurons (Shen et al. 2002) and to suppress NO-
induced apoptosis by stimulating of Bcl-2 expression
in immortalized pineal PGT-b cells (Yoo et al. 2002).
In a previous publication, we have demonstrated
that the number of neurons in the hilus of the dentate
gyrus was significantly decreased during aging and
that chronic GH treatment was able to prevent this
neuronal loss. These findings indicated that GH
administration might prevent some of the aging
associated with this hippocampal area alteration
(Azcoitia et al. 2005). Since no increase in neurogen-
esis was detected, the maintenance of the neuronal
population could be probably due to a reduction of
apoptosis. However, previous data supporting this
potential pathway were obtained only in whole rat
brain (Tresguerres et al. 2008) but not specifically in
the denate gyrus.
So, the aim of the present study was to investigate if
chronic treatments with exogenous GH and melatonin
were able to reduce the increased apoptosis processes
observed in the dentate gyrus of old male Wistar rats,
leading to a reduction in the total number of neurones




Male Wistar rats of 2 (6–8 % lifespan) and 22 months
(70–75 % lifespan) of age were used. Animals were
obtained from Harlan Iberica (Barcelona, Spain) and
maintained at a constant temperature (21 ± 2 C) on a
12-h light/dark cycle and standard laboratory rat chow
(A04 Panlab, Barcelona, Spain) with free access to
food and water. Rats were treated according to the
guidelines of the European Community Council
Directives 86/6091 EEC. The average lifespan of
Wistar rats in the laboratory was *34–36 months.
Old animals were divided in three groups at
22 months of age. Untreated control rats (group 1),
rats treated with hGH, (group 2) and animals treated
with melatonin (group 3). Rats were sacrificed in
groups of n = 12/13 at more than 24 months of age.
Melatonin (Actafarma, Madrid, Spain) was given in
the drinking water at a dose of 1 mg/kg/day for
10 weeks. A fresh melatonin solution was prepared 3
times per week, depending on the water consumption
and the weight of the animals to obtain a melatonin
dose of 1 mg/kg/day. Water bottles were covered with
aluminium foil to protect them from light, and the
drinking fluid was changed 3 times weekly. Melatonin
was given over 24 h, but we need to take into account
that during the day these animals were sleeping, so,
normally more than 80 % of the water was drunk
during there activity phase, in the night.
Treatment with hGH (Sandoz, Germany) was
performed twice daily by sc injections at a dose of
1 mg/kg for 2.5 months (Azcoitia et al. 2005; Tres-
guerres et al. 2008). We need to take into consideration
that the GH used was of human origin, so that the
response was not the same as for rat GH. On the other
hand, small animals needed a much higher dosage than
humans, as was demonstrated by Mordenti and
Chappell (1989).
Untreated animals were injected with saline twice
daily. A group of 2-months-old animals (n = 12) was
used as reference control. After the treatment period,
animals were sacrificed by decapitation and dentate
gyrus samples were immediately dissected. Dentate
gyrus was dissected under a binocular as described
(Lein et al. 2004; Hagihara et al. 2009), immediately
frozen in liquid nitrogen, and stored at -80 C until
use.
Extraction of tissue samples and determination
of HSP 70
Dentate gyrus were quickly dissected and frozen in
liquid nitrogen. Frozen organ samples were trans-
ferred to 5-ml polypropylene tubes containing 19
Extraction reagent (4 C) with protease inhibitors
(0.1 mM PMSF, 1 lg/ml leupeptin, 1 lg/ml aproti-
nin, 1 lg/ml pepstatin). Samples were homogenized
for 30 s with an electrical homogenizer (Polytron;
Brinkmann Instruments, Westminster, NY, USA) and
later centrifuged at 21,0009g (10 min, 4 C). The
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supernatant collected and were stored at -80 C until
assayed for the quantitative presence of HSP 70.
HSP 70 was measured with an ELISA kit according
to the manufacturer’s instructions (Assay designs,
Stressgen, MI, USA, catalog number: EKS-700B).
A mouse monoclonal antibody specific for induc-
ible HSP 70 is pre-coated on the well of the provided
HSP 70 Immunoassay Plate. Inducible HSP 70 is
captured by the immobilized antibody and is detected
with a HSP 70 specific rabbit polyclonal antibody. The
rabbit polyclonal antibody is subsequently bound by a
horseradish peroxidase conjugated anti-rabbit IgG
secondary antibody. The assay is developed with
tetramethylbenzidine (TMB) substrate and blue color
develops in proportion to the amount of captured HSP
70. The color development is stopped with acid stop
solution. The intensity of the color is measured in
microplate reader at 450 nm. HSP 70 concentrations
from the sample are quantitated by interpolating
absorbance reading from a standard curve generated
with the calibrated HSP 70 protein standard provided.
Western blotting analysis
Western blots were used to measure the protein
expression of Bax, Bcl-2-associated death promoter
(Bad), myeloid cell leukemia-1 (Mcl-1) and Bcl-2.
Briefly, dentate gyrus samples after homogenization
with lysis buffer were sonicated, boiled with gel-
loading buffer (0.100 M Tris–HCl; 4 % SDS; 20 %
glycerol; 0.1 % bromophenol blue) in the ratio 1:1,
and protein concentrations were determined by the
Bradford methods. Total protein equivalents
(25–30 lg) for each sample were separated by SDS-
PAGE by using 10 % acrylamide gels and were
transferred onto nitrocellulose membrane in a semi-
dry transfer system. The membrane was immediately
placed into blocking buffer containing 5 % nonfat
milk in 20 mM Tris, pH 7.5; 150 mM NaCl; and
0.01 % Tween-20. The blot was allowed to block at
37 C for 1 h. The membrane was incubated with
rabbit polyclonal Bax, Bad, Bcl-2 and with goat
polyclonal Mcl-1 (Gene Tex, Inc., CA, USA)
(1:1,000) for 2 h at 25–27 C, followed by incubation
in an anti-rabbit or anti-goat IgG-horseradish perox-
idase conjugated antibody (1:4,000). After washing
with T-TBS, the membranes were incubated with ECL
Plus detection reagents (Amersham Life Science Inc.,
Buckinghamshire, UK), exposed to X-ray film. The
films were scanned with densitometer (BioRad GS
800) to determine the relative optical densities. Pre-
stained protein markers were used for molecular
weight determinations.
RNA isolation and RT-PCR
RNA was isolated from dentate gyrus samples of male
rats using the TRI Reagent Kit (Molecular Research
Center, Inc., Cincinnati, OH), following the manufac-
turer’s protocol. The purity of the RNA was estimated
by 1.5 % agarose gel electrophoresis, and RNA
concentration was determined by spectrophotometry
(260 nm). Reverse transcription of 2 lg RNA for
cDNA synthesis was performed using the Reverse
Transcription System, (Promega, Madison, WI, USA)
and a pd(N)6 random hexamer. RT-PCR was per-
formed in an Applied Biosystems 7300 apparatus
using the SYBR Green PCR Master Mix (Applied
Biosystems, Warrington, UK) and 300 nM concentra-
tions of specific primers (Table 1). The thermocycling


























18s was used as a housekeeping gene to compare the samples
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profile conditions used were: 50 C for 2 m, 95 C for
10 m, 95 C for 15 s, 60 C for 1 m, 95 C for 15 s,
60 C for 30 s and 95 C for 15 s. For the normali-
zation of cDNA loading in the PCR reaction, the
amplification the 18S rRNA for every sample was
used. Relative changes in gene expression were
calculated using the 2-DDCT method.
Statistical analyses
The results were statistically analyzed with the
ANOVA method and a confidence level of 95 %
(p \ 0.05) was considered significant. Results are
expressed as the mean ± SEM. Mean comparison was
done by the ANOVA analysis of variance followed by
a Fisher test.
Results
HSP 70 levels, which are known to prevent apoptosis,
were decreased in the dentate gyrus of old male rats as
compared to young ones (p B 0.03). Administration of
GH (p B 0.01) and melatonin (p B 0.05) significantly
elevated the levels of HSP 70 in hippocampus of old
rats, with GH showing a more marked effect (Fig. 1).
The gene expressions of pro-apoptotic markers like
Bax (p B 0.01) and Bad (p B 0.05) were increased in
the dentate gyrus of old males as compared to young
controls (Fig. 2). Melatonin treatment decreased the
expression of Bad (p B 0.001) and Bax (p B 0.001) in
dentate gyrus of old animals. However, GH was only
able to diminish the mRNA expression of Bax
(p B 0.001), but not of Bad (Fig. 2).
A slight age-related decrease of Bcl-2 expression in
the dentate gyrus was evident in the study, but this
trend did not show significant differences. When old
rats were treated with GH or melatonin the expression
of Bcl-2 did not show significant changes (Fig. 3).
However, the Bcl-2/Bax ratio was higher in the group
of young animals as compared to old and treatment
with GH and melatonin were able to increase this
parameter, thus showing that cells in this area of the
hippocampus were protected from apoptosis.
The mRNA expressions of XIAP (p B 0.05) and
NIAP (p B 0.05) were decreased in dentate gyrus of
24 month old when compared to 2 month old male
rats (Fig. 4). When old males were treated with GH,
significant increases of gene expression of XIAP
(p B 0.01) and NIAP (p B 0.01) were observed. After
chronic treatment with melatonin a significant
increase in mRNA expression of NIAP (p B 0.01)
was detected, whereas XIAP expression did not show
any change (Fig. 4).
Fig. 1 Level of HSP 70 in dentate gyrus of young and old male
rats and effect of chronical treatments with melatonin and GH.
Data represent mean ± SEM
Fig. 2 mRNA (n = 7/8) expression of BAD and BAX in
dentate gyrus of young and old male rats and effect of chronical
treatments with melatonin and GH. Data represent
mean ± SEM
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This hippocampus area of aged rats showed a highly
significant increase in mRNA expression of apoptosis-
inducing factor (AIF) (p B 0.001). Administration of
melatonin and GH to old males significantly lowered its
mRNA expression (p B 0.01) (Fig. 5).
Aging induced also a significant decrease in the
expression of SIRT1 (p B 0.05) and SIRT2 (p B 0.05)
in the dentate gyrus (Fig. 6). The expression of SIRT2
gene was significantly up-regulated after GH replace-
ment (p B 0.05), but melatonin did not produce any
effect on this parameter in the group of old male rats
(Fig. 6). However, the mRNA expression of SIRT1
was significantly increased in the dentate gyrus of old
males, but only after melatonin treatment (p B 0.001)
(Fig. 6).
Western blot results showed that Bax (p B 0.01)
and Bad (p B 0.005) protein expressions were up
regulated during aging (Fig. 7). When old animals
were treated with melatonin, a significant reduction of
both proteins could be observed (p B 0.01). However
treatment with GH to old males was only able to
reduce Bax protein (p B 0.005) in the dentate gyrus
(Fig. 7). Aging decreased the expression of Mcl-1
protein (p B 0.05) and treatment with melatonin was
able to significantly increase this parameter
(p B 0.001) (Fig. 8). In the case of Bcl-2 protein,
results obtained by Western blotting correlated with
data obtained by PCR analysis. Bcl-2 protein levels
demonstrated a tendency to decrease during aging, and
treatments with GH and melatonin were not able to
change this parameter (Fig. 9).
In addition, we also demonstrated that expression of
IGFI was decreased in dentate gyrus of old male rats
(p B 0.02) and treatment with GH was able to signif-
icantly increase this parameter (p B 0.02) (Fig. 10).
Discussion
In the present paper, we have demonstrated that aging
induced significant increases in gene and protein
Fig. 3 mRNA (n = 7/8) expression of Bcl-2 in dentate gyrus
of young and old male rats and effect of chronical treatments
with melatonin and GH. Data represent mean ± SEM
Fig. 4 Expression of mRNA XIAP and NIAP in the dentate
gyrus of young and old male rats and effect of administration of
melatonin and GH. Data represent mean ± SEM (n = 7/8)
Fig. 5 Expression of mRNA AIF in the dentate gyrus of young
and old male rats and effect of administration of melatonin and
GH. Data represent mean ± SEM (n = 7/8)
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expressions of pro-apoptotic markers (Bax and Bad) in
the dentate gyrus of male rats. Tehranian et al. (2008)
found that after cortical contusion injury Bax null mice
were able to lose less hippocampal cells and showed
increased hippocampal neurogenesis. Results
obtained in our research are in accordance with data
demonstrating that expressions of Bax and Bid protein
in old-aged animals were significantly higher than in
the young-control group (Thees et al. 2005; Kim et al.
2010). Our results also demonstrated an increase in the
mRNA expression of AIF in the dentate gyrus of old
rats and this could suggest, that this brain area was
following different apoptotic pathways. Reix et al.
(2007) reported that the ‘‘apoptotic-inducing’’ 57 kDa
isoform of AIF was increased with age and these
authors suggest that the prevalence of AIF-dependent
programmed cell death in cerebral cortex was also
increased with age.
Another point of our research was the consequence
of the expression of proteins and genes with opposite
effects on apoptosis. So, we have demonstrated that
during aging the expression of Bcl-2 gene and proteins
did not change in the dentate gyrus of male Wistar rats.
However, the Bcl-2/Bax ratio was significantly higher
in the group of young animals as compared with old,
indicating a lower level of apoptosis. The Bax/Bcl-2
balance was one of the critical factors determining
whether the cells showed undergo apoptosis, and this
balance was actually altered during aging (Thees et al.
2005). Interestingly, our present findings indicated
that during aging the protein expression of Mcl-1 was
decreased, but no changes in the expression of Bcl-2
gene and protein in the dentate gyrus were detected.
Yang et al. (2012) demonstrated significant reduction
in Mcl-1 expression at both the mRNA and the protein
levels and the ratio of expression levels of Mcl-1/Bax
genes in the aging subjects. Rapid reduction of Mcl-1
mRNA and protein levels are early events after DNA
Fig. 6 The expression of mRNA SIRT1 and SIRT2 in the
dentate gyrus of young and old male rats and effect of
administration of melatonin and GH. Data represent mean ± -
SEM (n = 7/8)
Fig. 7 Protein expression of BAD and BAX detected by
Western blot in dentate gyrus of young and old male rats and
effect of chronical treatments with melatonin and GH. Data
represent mean ± SEM (n = 4/5)
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damage in neurons, and maintaining high Mcl-1 levels
can protect neurons against death (Arbour et al. 2008).
The present study demonstrated that aging was able
to affect negatively the gene expression of XIAP and
NIAP in the dentate gyrus of old male rats. In vitro
studies reported that upregulation of NIAP and
decreased interaction of NIAP with its endogenous
inhibitor, Smac, by the presence of neurotrophin-3, did
actually protected neurons from Ab induced death
(Lesne´ et al. 2005). Trapp et al. (2003) reported that
transgenic XIAP-overexpressing mice showed
reduced caspase-3 activation and fewer cells with
DNA fragmentation.
The brain is exposed to chronic oxidative stress
during aging (Rastogi et al. 2012). As result, there is a
gradual accumulation of damaged proteins and a
functional decline in the brain’s endogenous defense
system (Rumora et al. 2007; Min et al. 2008). Our
results clearly indicated that levels of HSP 70 were
decreased in the dentate gyrus of old male rats. These
findings are in consonance with the results obtained by
Pardue et al. (1992) and Galli et al. (2006), in which
HSP 70 induction and constitutive HSC 70 values are
lower with age in hippocampus. Other authors dem-
onstrated that HSP 72 blocked apoptosis primarily by
inhibiting translocation of the pro-apoptotic Bcl-2
family member Bax, thereby preventing the release of
pro-apoptotic factors from mitochondria (Stankiewicz
et al. 2005) and inhibiting AIF translocation to the
nucleus (Matsumori et al. 2005).
Our data showed that the expression of SIRT1 was
decreased in the dentate gyrus of old rats. A decrease
in extracellular signal-regulated kinase 1/2 phosphor-
ylation and altered expression of hippocampal genes
involved in synaptic function, lipid metabolism, and
myelinization were also detected in SIRT1-KO mice.
By contrast, mice with high levels of SIRT1 expres-
sion in the brain exhibited normal synaptic plasticity
and memory (Micha´n et al. 2010). Palla`s et al. (2008)
have demonstrated in the senescence-accelerated
prone mice (SAMP-8), a progressively decreased
SIRT1 expression. Lafontaine-Lacasse et al. (2010)
have shown that Sirt1 mRNA levels were strongly
decreased by aging in the arcuate nucleus. It has been
also reported that specific activity of SIRT1 was
Fig. 8 Western blot analysis of Mcl-1 protein expression in the
dentate gyrus of young and old male rats and effect of
administration of melatonin and GH. Data represent mean ±
SEM (n = 4/5)
Fig. 9 Protein expression of Bcl-2 detected by Western blot in
the dentate gyrus of young and old male rats and effect of
administration of melatonin and GH. Data represent mean ±
SEM (n = 4/5)
Fig. 10 The expression of mRNA IGF1 in the dentate gyrus of
young and old male rats and effect of administration of
melatonin and GH. Data represent mean ± SEM (n = 7/8)
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decreased with aging and this could impact the age-
associated protein acetylation levels in the cerebellum
(Marton et al. 2010). SIRT2 has been related to
synaptic plasticity, learning and memory that are also
in turn related to neuronal motility and migration.
SIRT2 has also been implicated in neuronal growth
cone motility (Harting and Knoll 2010). The data
presented here, showed significantly decreased SIRT2
expressions in the dentate gyrus of old male rats.
In our study GH administration was found to
increase expression on XIAP, NIAP, SIRT2 and HSP
70 levels and to decrease the expression of pro-
apoptotic markers like Bax and AIF. These results
demonstrated that GH was able to regulate different
(extrinsic and intrinsic) pathways of the apoptotic
process in the dentate gyrus of old male rats. The
mechanism of regulation of apoptosis by GH could be
direct or in-direct, via induction of IGF-1 production
and in the literature several results seemed to confirm
this. We have demonstrated that the mRNA expression
of IGF-1 that showed an age associated decrease in the
dentate gyrus in male rats could be restored by GH
treatment. Thus restoration of physiological levels of
GH/IGF-1 axis was able to influence on the molecular
pathways that lead to a reduction in apoptosis.
Mechanisms underlying GH-mediated regulation of
apoptosis include activation of the phosphatidylinosi-
tol 3-kinases (PI3K)-Akt pathway (Jeay et al. 2002),
reduction of Bax (Kolle et al. 2002) and increasing
Bcl-2 expression (Haeffner et al. 1999). Treatment
with GH decreased LDH release, Bax/caspase-3
activity and increased Bcl-2 expression compared
with Ab treatment in a human neuroblastoma cell line
(Zhang et al. 2010). Svensson et al. (2008) also found
that treatment with GH is capable of preventing or
even repairing morphine-induced damage to hippo-
campal cells by decreasing the caspase-3 activity and
increasing the neuronal cell density. Reduction of
apoptosis has also been shown by our group to have a
positive effect on behavior in old male rats like
memory tasks performed in the radial maze and motor
ability in the Rotarod treadmill (Esteban et al. 2010).
GH improved working memory processes through
both NMDA and AMPA glutamatergic receptors and
it required the activation of extracellular MEK/ERK
signalling pathway. These effects could be related to
the enhancement of excitatory synaptic transmission
in the hippocampus reported by GH administration
(Ramis et al. 2013).
Besides exhibiting well known antioxidant proper-
ties, melatonin also has been shown to protect
neuronal cells from oxidative stress and apoptosis as
induced by mitochondrial DNA deletion (Alvira et al.
2006; Jou et al. 2007). An important observation of the
present study is that chronic treatment with melatonin
did actually reduce the expression of Bax and Bad in
the dentate gyrus of old male rats. These findings
together with previous results indicating that melato-
nin was able to inhibit H2O2-induced apoptosis in
cultured rat astrocytes, point to its ability to down
regulate Bax expression and to inhibit caspase-3
activation (Juknat et al. 2005). Baydas et al. (2005)
found that chronic melatonin administration markedly
reduced the hyperhomocysteinemia-induced rise in
mitochondrial Bax levels, restoring cytosolic Bax
values and inhibiting caspase-9 activation in the
hippocampus. In Tg mice (a model of Alzheimer’s
disease) early melatonin supplementation, prevented
the abnormal upregulation of Bax, caspase-3 and Par-4
(prostate apoptosis response-4) in cortex neurons
(Feng et al. 2006). The other, possible, mechanism
of action of melatonin is its upregulation of anti-
apoptotic proteins, as has been demonstrated by
several authors. So, melatonin increased Bcl-2 and
augmented expression of XIAP in ethanol-treated
HN2-5 (mouse hippocampal neuron-derived) cells
(Shetha et al. 2009). Nopparat et al. (2010) have
demonstrated, in the SK-N-SH dopaminergic cell line,
a novel role of melatonin in protecting cells from
autophagic cell death triggered by the Bcl-2/Beclin 1
pathway, inhibiting the activation of the JNK1 (c-Jun
amino-terminal kinase), Bcl-2 upstream pathway. In
the present study, melatonin treatment was not able to
change the expression of Bcl-2 and XIAP, but
significantly increased gene expression of NIAP,
Mcl-1 protein levels and could maintain a favourable
B-cell lymphoma 2 (Bcl-2)/Bax ratio in the dentate
gyrus of old rats. In addition, we have also observed
that melatonin was able to decrease mRNA expression
of AIF. Our data were in agreement with previous
reports in which melatonin was able to prevent the
insult related release of AIF from mitochondria
(Andrabi et al. 2004). One of the most important
changes that we have observed in aged dentate gyrus
after melatonin treatment was the increase in the
expression of SIRT1, which was consistent with
finding by Gutierrez-Cuesta et al. (2008), who exam-
ined the effects of melatonin stimulating survival
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processes in senescence-accelerated (SAMP8) and
resistant mice (SAMR1). The same group has also
demonstrated that melatonin exerted a neuroprotective
role through the SIRT1 pathway (Tajes et al. 2009).
In conclusion, aging in the dentate gyrus is
associated with increased expression of pro-apoptotic
genes and proteins, like Bax, Bad, AIF and decreased
anti-apoptotic ones such as Mcl-1, XIAP and NIAP.
We reported also a decrease in expression of SIRT1
and SIRT2 in the dentate gyrus of old male rats. Both
treatments have been shown to modulate the pro-
antiapoptotic ratio and increase sirtuins expression
restoring the situation found in young animals. Our
data demonstrated that melatonin and growth hormone
could exert a protective effect on hippocampal damage
induced by aging. Further studies of the survival
signalling pathways may provide novel therapeutic
strategies for preventive of age-related disease to
prevent age-related alterations.
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